Biotech veteran John Maraganore raises $135 million for his ‘next-generation RNAi’ startup

News

Oct 8

Written By Matthew Zola

News

Matthew Zola

City Therapeutics breaks ground with $135M and blueprints from RNAi expert John Maraganore

City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine